Literature DB >> 7515151

Variable domain-identical antibodies exhibit IgG subclass-related differences in affinity and kinetic constants as determined by surface plasmon resonance.

L J Cooper1, D Robertson, R Granzow, N S Greenspan.   

Abstract

We have analysed the binding of variable domain-identical mouse monoclonal antibodies (mAb) of the IgG3, IgG1 and IgG2b subclasses, as well as F(ab')2 fragments derived from the IgG3 and IgG1 mAb, to a multivalent glycoprotein target. Using a biosensor device (BIAcore, Pharmacia Biosensor) that measures the mass of the antibody (or other receptor molecule) deposited on a sensor chip displaying the relevant epitopes, we found that the IgG3 mAb binds more effectively than the other antibody species at a high but not a low epitope density. The greater functional affinity associated with the IgG3 mAb, at high epitope density, was correlated with both slower dissociation rate constants and faster association rate constants in comparison with the IgG1 and IgG2b mAb and the F(ab')2 fragments derived from the IgG3 and IgG1 mAb. Evidence for slower dissociation kinetics for the IgG3 mAb versus the IgG1 and IgG2b mAb was also obtained by ELISA and flow cytometry. These results demonstrate that: (1) differences in heavy chain constant (CH) domains can significantly influence apparent functional affinity for multivalent antigen, as determined without the use of covalently modified primary or secondary antibodies; (2) differences in CH domains can alter both association and dissociation rate constants for interactions between IgG antibodies and multivalent antigen; and (3) these effects of CH domains depend on epitope density. The effect of constant region differences on the apparent association rate constants suggests new approaches for achieving better binding or functional effectiveness through antibody engineering.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515151     DOI: 10.1016/0161-5890(94)90165-1

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  29 in total

1.  Immunoglobulin KM genes in Guillain-Barré syndrome.

Authors:  Janardan P Pandey; Christian A Vedeler
Journal:  Neurogenetics       Date:  2003-02-11       Impact factor: 2.660

2.  Human constant regions influence the antibody binding characteristics of mouse-human chimeric IgG subclasses.

Authors:  N McCloskey; M W Turner; P Steffner; R Owens; D Goldblatt
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

3.  Utilizing ESEEM spectroscopy to locate the position of specific regions of membrane-active peptides within model membranes.

Authors:  Raanan Carmieli; Niv Papo; Herbert Zimmermann; Alexey Potapov; Yechiel Shai; Daniella Goldfarb
Journal:  Biophys J       Date:  2005-10-28       Impact factor: 4.033

4.  High affinity mouse-human chimeric Fab against hepatitis B surface antigen.

Authors:  Biplab Bose; Navin Khanna; Subrat K Acharya; Subrata Sinha
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

5.  Generation and characterization of high affinity humanized fab against hepatitis B surface antigen.

Authors:  Ashutosh Tiwari; Durgashree Dutta; Navin Khanna; Subrat K Acharya; Subrata Sinha
Journal:  Mol Biotechnol       Date:  2009-03-27       Impact factor: 2.695

6.  Can immunoglobulin C(H)1 constant region domain modulate antigen binding affinity of antibodies?

Authors:  O Pritsch; G Hudry-Clergeon; M Buckle; Y Petillot; J P Bouvet; J Gagnon; G Dighiero
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

7.  Kinetics of ligand binding to receptor immobilized in a polymer matrix, as detected with an evanescent wave biosensor. I. A computer simulation of the influence of mass transport.

Authors:  P Schuck
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

8.  Variable region identical immunoglobulins differing in isotype express different paratopes.

Authors:  Alena Janda; Ertan Eryilmaz; Antonio Nakouzi; David Cowburn; Arturo Casadevall
Journal:  J Biol Chem       Date:  2012-08-28       Impact factor: 5.157

9.  Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection.

Authors:  Paolo Muratori; Susan E Sutherland; Luigi Muratori; Alessandro Granito; Marcello Guidi; Georges Pappas; Marco Lenzi; Francesco B Bianchi; Janardan P Pandey
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

10.  Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus.

Authors:  Janardan P Pandey; Jacquie Astemborski; David L Thomas
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.